In silico and ex vivo drug screening identifies dasatinib as a targeted therapy for T-ALL

Saara Laukkanen (Contributor)

Activity: Talk or presentation › Conference presentation

Description

Contributors: Laukkanen Saara, Grönroos Toni, Pölönen Petri, Kuusanmäki Heikki, Cloos Jacqueline, Ossenkoppele Gert, Gjertsen Bjorn, Oystein Bruserud, Heckman Caroline, Heinäniemi Merja, Kontro Mika, Lohi Olli

Period	18 Mar 2017
Event title	T-ALL workshop in Leuven
Event type	Other
Degree of Recognition	International